SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from EXAGEN INC. (XGN) (CIK 0001274737) (XGN) — Sep 16, 2019

EXAGEN INC. (XGN) (CIK 0001274737)
Date: Sept. 16, 2019 · CIK: 0001274737 · Accession: 0001193125-19-245837

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-233446

Date
September 16, 2019
Author
COWEN AND COMPANY, LLC
Form
CORRESP
Company
EXAGEN INC. (XGN) (CIK 0001274737)

Letter

September 16, 2019

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention:

John Reynolds, Assistant Director

Ruairi Regan

Joanna Lam

Raj Rajan

Brigitte Lippman

Pam Howell

Re: Exagen Inc.

Registration Statement on Form S-1 (File No. 333-233446)

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 9, 2019 and the date hereof, approximately 966 copies of the Preliminary Prospectus dated September 9, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on September 18, 2019 or as soon thereafter as practicable.

[Signature page follows]

Very truly yours,
COWEN AND COMPANY, LLC

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 September 16, 2019

United States Securities and Exchange Commission

 Division of
Corporation Finance

 100 F Street, N.E.

 Washington, DC 20549

Attention:

 John Reynolds, Assistant Director

 Ruairi Regan

 Joanna Lam

 Raj Rajan

Brigitte Lippman

 Pam Howell

Re:
 Exagen Inc.

Registration Statement on Form S-1 (File No. 333-233446)

Ladies and Gentlemen:

 Pursuant to Rule 460 of the General Rules
and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 9, 2019 and the date hereof, approximately 966 copies of the Preliminary Prospectus dated September 9, 2019 were distributed to
prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

 We wish to
advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00
p.m. Eastern Time, on September 18, 2019 or as soon thereafter as practicable.

 [Signature page follows]

 Very truly yours,

COWEN AND COMPANY, LLC

 CANTOR FITZGERALD & CO.

WILLIAM BLAIR & COMPANY, L.L.C.

 As representatives of
the Underwriters

By:

Cowen and Company, LLC

By:

 /s/ E. James Streator III

Name: E. James Streator III

Title: Managing Director

By:

Cantor Fitzgerald & Co.

By:

 /s/ Sage Kelly

Name: Sage Kelly

Title: Head of Banking

By:

William Blair & Company, L.L.C.

By:

 /s/ Steve Maletzky

Name: Steve Maletzky

Title: Partner, Equity Capital Markets

 [Signature page to Acceleration Request]